ECS
ECSBOTANIC FPO [ECS]
Healthcare · ASX Small Cap
$0.0060 +20.0%
Updated 21 Jul 2026 · Signals refresh every scan
Get alerts when ECS triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Pressing against the upper Bollinger Band — extended and may need to cool off
- Trading above both moving averages — the trend is your friend here
- Volume surging at 5.4x normal while price climbs — real buying conviction behind this move
- Just broke above 20-day resistance — a level that was capping price, now cleared
- On a tear — up 20.0% over the last 5 days
- Beating the Small Ords index — relative strength of 1.43, so it's outpacing the pack
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (16 quarters)
- Very high P/S ratio (2211.4x)
- Moderate revenue growth (+16%)
- Micro-cap ($5-20M) - high risk
- CANSLIM A: Turned profitable
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (2.92%/day)
- Altman Z-Score distress zone (0.49 < 1.81, low-confidence approx)
- Penny stock risk ($0.005)
- RBA hiking (-3pts)
Risk Signals
- RSI is running hot — overbought territory, so expect some pullback risk
- Stochastic is stretched into overbought — could need a breather
- RSI is overbought but volume confirms it — this could be genuine momentum, not just froth
- Piotroski F-Score weak (2/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 25% over the past year
Ask Scout AI about ECS
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW Quarterly Activities/Appendix 4C Cash Flow Report
NONE German GMP Update Reinforces ECS Manufacturing Strategy
NONE Cleansing Statement
NONE Application for quotation of securities - ECS
Recent ASX Announcements
| 2026-07-19 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-07-02 | German GMP Update Reinforces ECS Manufacturing Strategy PRICE SENSITIVE |
| 2026-07-01 | Cleansing Statement |
| 2026-07-01 | Application for quotation of securities - ECS |
| 2026-07-01 | Change of Director's Interest Notice |
Key Metrics
$8.0M
Market Cap
1.9M
Avg Volume
5.4x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
N/A
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | insufficient_data | Float: 0% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
111 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track ECS and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required